Cargando…

IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children

Genetic polymorphisms within the IFNL3/IFNL4 genomic region, which encodes type III interferons, have been strongly associated with clearance of hepatitis C virus. We hypothesized that type III interferons might be important for the immune response to other pathogens as well. In a cohort of 914 Mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prokunina-Olsson, Ludmila, Morrison, Robert D., Obajemu, Adeola, Mahamar, Almahamoudou, Kim, Sungduk, Attaher, Oumar, Florez-Vargas, Oscar, Sidibe, Youssoufa, Onabajo, Olusegun O., Hutchinson, Amy A., Manning, Michelle, Kwan, Jennifer, Brand, Nathan, Dicko, Alassane, Fried, Michal, Albert, Paul S., Mbulaiteye, Sam M., Duffy, Patrick E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042471/ https://www.ncbi.nlm.nih.gov/pubmed/33850301 http://dx.doi.org/10.1038/s41435-021-00127-7

Ejemplares similares

Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs
por: Paquin, Ashley, et al.
Publicado: (2016)

Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes
por: Fried, Michal, et al.
Publicado: (2018)

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
por: Gaoussou, Santara, et al.
Publicado: (2022)

Age-dependent increase in antibodies that inhibit Plasmodium falciparum adhesion to a subset of endothelial receptors
por: Attaher, Oumar, et al.
Publicado: (2019)

Antibody Levels to Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLγ11 and DBLδ-1 Predict Reduction in Parasite Density
por: Araj, Brittany N., et al.
Publicado: (2021)

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects
por: Onabajo, Olusegun O., et al.
Publicado: (2021)

A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
por: Doritchamou, Justin YA, et al.
Publicado: (2022)

Host factors that modify Plasmodium falciparum adhesion to endothelial receptors
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali
por: Andemel, Naissem, et al.
Publicado: (2020)

Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
por: Dicko, Alassane, et al.
Publicado: (2015)

Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2021)

Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2022)

IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children
por: Samayoa-Reyes, Gabriela, et al.
Publicado: (2021)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity
por: Rouf Banday, A., et al.
Publicado: (2021)

Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2
por: Onabajo, Olusegun O., et al.
Publicado: (2020)

IFNL4-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections
por: Minas, Tsion Zewdu, et al.
Publicado: (2018)

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa
por: Woodford, John, et al.
Publicado: (2022)

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
por: Stone, Will, et al.
Publicado: (2022)

Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio
por: Bradley, John, et al.
Publicado: (2019)

Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells
por: Onabajo, Olusegun O., et al.
Publicado: (2015)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Malaria Morbidity in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria in Mali: A Randomized Control Trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
por: Diawara, Fatou, et al.
Publicado: (2017)

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)

Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
por: Sagara, Issaka, et al.
Publicado: (2021)

Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019
por: O’Brien, Thomas R, et al.
Publicado: (2020)

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study
por: Sagara, Issaka, et al.
Publicado: (2021)

A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes
por: Meerstein-Kessel, Lisette, et al.
Publicado: (2018)

Epidemiology of migraine among students in Mali
por: Maiga, Youssoufa, et al.
Publicado: (2017)

Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise
por: Woodford, John, et al.
Publicado: (2022)

Evaluation of the Mercy weight estimation method in Ouelessebougou, Mali
por: Dicko, Alassane, et al.
Publicado: (2014)

Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
por: Oulton, Tate, et al.
Publicado: (2022)

Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou, Mali
por: Issiaka, Djibrilla, et al.
Publicado: (2020)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7vqocofmvr1etgvegai91r79j6